Meprin α and meprin β: Procollagen proteinases in health and disease

Matrix Biology

Volumn 44-46, Issue , 2015, Pages 7-13

  Prox, Johannes ^a   Arnold, Philipp ^a   Becker Pauly, Christoph ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Collagen assembly; Fibrosis; Meprin ; Meprin ; Metalloprotease; Procollagen proteinase

Indexed keywords

COLLAGEN; MEPRIN; MEPRIN ALPHA; MEPRIN BETA; UNCLASSIFIED DRUG; COLLAGEN TYPE 1; COLLAGEN TYPE 3; MEPRIN B; METALLOPROTEINASE; PROCOLLAGEN;

COLLAGEN FIBRIL; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; KELOID; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; PULMONARY HYPERTENSION; REVIEW; TENSILE STRENGTH; TRANSCRIPTION REGULATION; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHEMISTRY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; METABOLISM;

MUS;

ANIMALS; COLLAGEN TYPE I; COLLAGEN TYPE III; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKOUT TECHNIQUES; HUMANS; HYPERTENSION, PULMONARY; KELOID; METALLOENDOPEPTIDASES; MICE; PROCOLLAGEN; TENSILE STRENGTH;

EID: 84930761410     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2015.01.010     Document Type: Review

References (48)

1. Herzog C., et al. Meprin A and meprin alpha generate biologically functional IL-1beta from pro-IL-1beta. Biochem Biophys Res Commun 2009, 379:904-908.
2. Banerjee S., Bond J.S. Prointerleukin-18 is activated by meprin beta in vitro and in vivo in intestinal inflammation. J Biol Chem 2008, 283:31371-31377.
3. Schutte A., et al. Microbial-induced meprin beta cleavage in MUC2 mucin and a functional CFTR channel are required to release anchored small intestinal mucus. Proc Natl Acad Sci U S A 2014, 111:12396-12401.
4. Broder C., et al. Metalloproteases meprin alpha and meprin beta are C- and N-procollagen proteinases important for collagen assembly and tensile strength. Proc Natl Acad Sci U S A 2013, 110:14219-14224.
5. Broder C., Becker-Pauly C. The metalloproteases meprin alpha and meprin beta: unique enzymes in inflammation, neurodegeneration, cancer and fibrosis. Biochem J 2013, 450:253-264.
6. Minder P., Bayha E., Becker-Pauly C., Sterchi E.E. Meprinalpha transactivates the epidermal growth factor receptor (EGFR) via ligand shedding, thereby enhancing colorectal cancer cell proliferation and migration. J Biol Chem 2012, 287:35201-35211.
7. Kruse M.N., et al. Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors. Biochem J 2004, 378:383-389.
8. Crisman J.M., Zhang B., Norman L.P., Bond J.S. Deletion of the mouse meprin beta metalloprotease gene diminishes the ability of leukocytes to disseminate through extracellular matrix. J Immunol 2004, 172:4510-4519.
9. Arolas J.L., et al. Structural basis for the sheddase function of human meprin beta metalloproteinase at the plasma membrane. Proc Natl Acad Sci U S A 2012, 109:16131-16136.
10. Becker-Pauly C., et al. Proteomic analyses reveal an acidic prime side specificity for the astacin metalloprotease family reflected by physiological substrates. Mol Cell Proteomics 2011, 10(M111):009233.
11. Ohler A., Debela M., Wagner S., Magdolen V., Becker-Pauly C. Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation. Biol Chem 2010, 391:455-460.
12. Bien J., et al. The metalloprotease meprin beta generates amino terminal-truncated amyloid beta peptide species. J Biol Chem 2012, 287:33304-33313.
13. Jefferson T., et al. Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo. J Biol Chem 2011, 286:27741-27750.
14. Jefferson T., et al. The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin beta and ADAM10. Cell Mol Life Sci 2013, 70:309-333.
15. Tang J., Bond J.S. Maturation of secreted meprin alpha during biosynthesis: role of the furin site and identification of the COOH-terminal amino acids of the mouse kidney metalloprotease subunit. Arch Biochem Biophys 1998, 349:192-200.
16. Becker C., et al. Differences in the activation mechanism between the alpha and beta subunits of human meprin. Biol Chem 2003, 384:825-831.
17. Bertenshaw G.P., Norcum M.T., Bond J.S. Structure of homo- and hetero-oligomeric meprin metalloproteases. Dimers, tetramers, and high molecular mass multimers. J Biol Chem 2003, 278:2522-2532.
18. Sterchi E.E., Stocker W., Bond J.S. Meprins, membrane-bound and secreted astacin metalloproteinases. Mol Aspects Med 2008, 29:309-328.
19. Kronenberg D., et al. Processing of procollagen III by meprins: new players in extracellular matrix assembly?. J Invest Dermatol 2010, 130:2727-2735.
20. Biasin V., et al. Meprin beta, a novel mediator of vascular remodelling underlying pulmonary hypertension. J Pathol 2014, 233:7-17.
21. Becker-Pauly C., Broder C., Prox J., Koudelka T., Tholey A. Mapping orphan proteases by proteomics: meprin metalloproteases deciphered as potential therapeutic targets. Proteomics Clin Appl 2014, 8:382-388.
22. Schilling O., Overall C.M. Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat Biotechnol 2008, 26:685-694.
23. Schechter I., Berger A. On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain. Biochem Biophys Res Commun 1968, 32:898-902.
24. Kleifeld O., et al. Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nat Biotechnol 2010, 28:281-288.
25. Norman L.P., Jiang W., Han X., Saunders T.L., Bond J.S. Targeted disruption of the meprin beta gene in mice leads to underrepresentation of knockout mice and changes in renal gene expression profiles. Mol Cell Biol 2003, 23:1221-1230.
26. Banerjee S., et al. Balance of meprin A and B in mice affects the progression of experimental inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2011, 300:G273-G282.
27. Yura R.E., Bradley S.G., Ramesh G., Reeves W.B., Bond J.S. Meprin A metalloproteases enhance renal damage and bladder inflammation after LPS challenge. Am J Physiol Renal Physiol 2009, 296:F135-F144.
28. Hulmes D.J. Building collagen molecules, fibrils, and suprafibrillar structures. J Struct Biol 2002, 137:2-10.
29. Bourhis J.M., et al. Procollagen C-proteinase enhancer grasps the stalk of the C-propeptide trimer to boost collagen precursor maturation. Proc Natl Acad Sci U S A 2013, 110:6394-6399.
30. Bourhis J.M., et al. Structural basis of fibrillar collagen trimerization and related genetic disorders. Nat Struct Mol Biol 2012, 19:1031-1036.
31. Hopkins D.R., Keles S., Greenspan D.S. The bone morphogenetic protein 1/Tolloid-like metalloproteinases. Matrix Biol 2007, 26:508-523.
32. Asharani P.V., et al. Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. Am J Hum Genet 2012, 90:661-674.
33. Martinez-Glez V., et al. Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat 2012, 33:343-350.
34. Muir A.M., et al. Induced ablation of Bmp1 and Tll1 produces osteogenesis imperfecta in mice. Hum Mol Genet 2014, 23:3085-3101.
35. Apte S.S. A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J Biol Chem 2009, 284:31493-31497.
36. Pappano W.N., Steiglitz B.M., Scott I.C., Keene D.R., Greenspan D.S. Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases. Mol Cell Biol 2003, 23:4428-4438.
37. Colige A., et al. Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3. J Biol Chem 2002, 277:5756-5766.
38. Eferl R., et al. Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Proc Natl Acad Sci U S A 2008, 105:10525-10530.
39. Eferl R., Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003, 3:859-868.
40. Mittelstadt M.L., Patel R.C. AP-1 mediated transcriptional repression of matrix metalloproteinase-9 by recruitment of histone deacetylase 1 in response to interferon beta. PLoS One 2012, 7:e42152.
41. Wang Y.G., et al. Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression. Exp Mol Med 2012, 44:387-393.
42. Gauglitz G.G., Korting H.C., Pavicic T., Ruzicka T., Jeschke M.G. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2011, 17:113-125.
43. Humbert M., et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004, 43:13S-24S.
44. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997, 9:240-246.
45. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991, 1072:129-157.
46. Olsen J.V., et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127:635-648.
47. Matters G.L., Bond J.S. Expression and regulation of the meprin beta gene in human cancer cells. Mol Carcinog 1999, 25:169-178.
48. Madoux F., et al. Development of HTS assays and pilot screen for inhibitors of metalloproteases meprin alpha and beta. Biopolymers Sep 2014, 102(5):396-406.